Get the Stockscreener App
3.13
1.57%
-0.05
After Hours:
3.12
-0.010
-0.32%
Checkpoint Therapeutics Inc Stock (CKPT) Latest News
Checkpoint Therapeutics CEO sells $64,027 in stock - MSN
James F. Oliviero III Sells 9,233 Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Stock - MarketBeat
Checkpoint Therapeutics CFO sells shares worth $271,983 - MSN
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) CEO James F. Oliviero III Sells 10,331 Shares - MarketBeat
Checkpoint Therapeutics CEO sells $64,027 in stock By Investing.com - Investing.com South Africa
The Future of Immune Checkpoint Inhibitors Market: Industry Disruptions & Innovations to Expect - WICZ
Checkpoint Therapeutics CEO Sells Shares to Cover Tax Obligations - TradingView
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) CFO Sells $271,983.70 in Stock - MarketBeat
Insider Sale Alert: Checkpoint Therapeutics Inc [CKPT] – Is it Time to sell? - Knox Daily
Checkpoint Therapeutics CFO sells shares worth $271,983 By Investing.com - Investing.com Canada
The time has not yet come to remove your chips from the table: Checkpoint Therapeutics Inc (CKPT) - SETE News
Analyzing Ratios: Checkpoint Therapeutics Inc (CKPT)’s Financial Story Unveiled - The Dwinnex
Technical analysis of Checkpoint Therapeutics Inc (CKPT) stock chart patterns - US Post News
Checking in on Checkpoint Therapeutics Inc (CKPT) after recent insiders movement - Knox Daily
Checkpoint Therapeutics Inc (CKPT) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) stock most popular amongst individual investors who own 56%, while public companies hold 14% - Yahoo Finance
Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Profit Outlook - Simply Wall St
Short Interest in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Increases By 17.5% - MarketBeat
Reviewing LifeVantage (NASDAQ:LFVN) & Checkpoint Therapeutics (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics (NASDAQ:CKPT) Coverage Initiated by Analysts at D. Boral Capital - Defense World
Checkpoint Therapeutics stock initiated at Buy Rating by Borak Capital - Investing.com Canada
This PG&E Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
D. Boral Capital Initiates Coverage on Checkpoint Therapeutics (NASDAQ:CKPT) - MarketBeat
Checkpoint Therapeutics CFO signs new executive agreement By Investing.com - Investing.com Australia
Checkpoint Therapeutics CFO signs new executive agreement - Investing.com India
Geode Capital Management LLC Buys 124,787 Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics Signs Executive Agreement with CFO - TipRanks
Fortress Biotech subsidiary's drug application accepted by FDA - Investing.com Australia
Checkpoint Therapeutics Inc (NASDAQ: CKPT) Today’s Hot Stock - Stocks Register
State Street Corp Grows Stock Holdings in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Head to Head Contrast: Tyra Biosciences (NASDAQ:TYRA) and Checkpoint Therapeutics (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics CFO sells $1.08 million in stock - Investing.com India
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) CFO Sells 268,432 Shares - MarketBeat
James F. Oliviero III Sells 220,230 Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Stock - MarketBeat
Checkpoint Therapeutics CFO sells $1.08 million in stock By Investing.com - Investing.com Canada
Checkpoint Therapeutics CEO sells $3.07 million in stock By Investing.com - Investing.com Canada
Checkpoint Therapeutics: Updating My Strategy After Unloxcyt's Approval (NASDAQ:CKPT) - Seeking Alpha
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):